Latest news with #telemedicine
Zawya
18 hours ago
- Health
- Zawya
App-side manner: Why South Africa prefers telemedicine services?
Access to healthcare in South Africa is often uneven, with public health facilities plagued by a lack of staff and resources. This means that many South Africans have to turn to telemedicine (video calls, apps, or online platforms) services for access to primary care. 'It is, therefore, important to tailor primary care telemedicine services in a way that builds and maintains patients' trust — especially given the sensitivity around health-related needs. Providers have a significant opportunity to receive and treat patients when they're often at their most vulnerable and should always do so with the utmost care and respect,' says Dr Grethe van Tonder, who recently obtained her doctorate in business management at Stellenbosch University. 'We need to understand the driving factors in patients' unique contexts causing them to continue using (app-based) primary care telemedicine services to make sure this kind of service delivery can continue to benefit South Africa's healthcare system in the long run,' adds Van Tonder. As part of her study, Van Tonder focused on the Kena Health app that was developed by Kena Health and was launched in 2022. It connects users to nurses, doctors and mental health professionals via text, audio, or video, and provides medical advice, diagnoses, prescriptions, sick notes, referrals, and mental health counselling — all without requiring scheduled appointments. The privacy perception Her study identified two novel factors influencing the acceptance of app-based telemedicine for primary care, specifically considering the South African public sector context: perception of privacy and perception of care. Prior theories had not included these perceptions as factors influencing the acceptance of telemedicine. According to Van Tonder, privacy perception refers to the extent to which an individual may perceive a telemedicine service as more or less private than in-person healthcare alternatives. 'While prior literature often associates telemedicine with more privacy risks compared to in-person alternatives, the study found that patients preferred the perceived privacy of app-based teleconsultations to in-person consultations at public clinics — the latter generally being the frame of reference of the research participants. 'During data collection, participants explained that app-based consultations allow for 'anonymity' where they don't have to be seen — such as when text or voice calls are used instead of video. 'Furthermore, others can't overhear their conversations with the healthcare professional, unlike in many under-resourced public healthcare facilities. 'Participants regard these circumstances as key to their acceptance of the app-based telemedicine service.' Van Tonder says patients' care perception had the strongest statistical effect on their acceptance of the telemedicine service and encompasses aspects such as empathy, kindness and respect associated with the telemedicine service experience. 'Participants repeatedly said their experience of receiving treatment through the app-based telemedicine service is very different from what they were used to at public healthcare facilities, like clinics, which they would normally rely on if telemedicine weren't available. 'They added that overburdened public healthcare facilities often don't allow private conversations with a healthcare professional. 'Staff tend to be rude and rushed, leaving patients without a chance to fully explain their symptoms and concerns. 'Consequently, patients often feel disrespected, as if the healthcare professional made a diagnosis without adequately enquiring about their actual needs or concerns.' App-side manner Van Tonder adds that participants also described being shouted at or scolded by medical staff, which often left them feeling judged and ashamed of the healthcare need that brought them to the public facility in the first place. 'In contrast to such experiences, participants said their interactions with healthcare professionals on the Kena Health app were the exact opposite — highlighting how their highly positive perceptions of care shaped their acceptance of, their satisfaction with, and their willingness to continue using the app-based telemedicine service.' The study found that patients' experience of genuine care while consulting with healthcare professionals via the Kena Health app had the strongest statistical effect on their acceptance of this telemedicine service. It further had statistically significant effects on their satisfaction with the service, as well as their general trust in this type of primary healthcare service delivery. 'Whether the consultation happened via text, phone call, or video, many said that feeling listened to and cared for was pivotal for their acceptance of the service.' Delivery-based pharmacy Van Tonder states her study could help app-based telemedicine service providers of primary care to tailor their services according to patient-specific needs, considering patients' unique contexts and frames of reference to address the factors that would most significantly influence their acceptance of such a service. The insights could also benefit other healthcare providers looking to add app-based telemedicine services to their existing offerings. She says that even though a digital platform is used, the human ability to show empathy, kindness and genuine care is what primary healthcare providers should focus on to build patient trust and satisfaction during app-based digital consultations. Asked what she would change about the use of telemedicine, especially in the public healthcare sector, Van Tonder responds: 'To enhance patient care, pharmacy services could be included in the service offering in future. 'While app-based telemedicine for primary care improves access to consultations and prescriptions, patients who typically rely on the public sector may still face challenges in obtaining their prescribed medication. 'Adding a delivery-based pharmacy service to an app-based primary care telemedicine platform could help patients access essential medication quickly, promoting faster recovery after consultation.'
Zawya
2 days ago
- Health
- Zawya
Jordan: Crown Prince inaugurates Jordan Digital Health Centre in Salt
AMMAN — HRH Crown Prince Hussein bin Abdullah II on Tuesday inaugurated the Jordan Digital Health Centre in Salt, which was established as part of the National Council for Future Technology's efforts to raise the level of medical services provided to citizens. The Crown Prince toured the Abu Dhabi Fund for Development-funded centre, which includes digital units for dialysis, radiology, intensive care and telemedicine services, and seeks to save time and effort for patients, and improve access to specialised care for rare medical specialities, according to a Royal Court statement. His Royal Highness listened to a briefing by Health Minister Firas Al Hawari about the remote medical services provided by the centre, whereby patients can communicate through voice or video calls with doctors following diagnosis to receive medical consultations. The minister said the centre has been connected to five major public hospitals and three healthcare centres as part of the first phase, adding that the second phase will expand to connect other public hospitals and healthcare centres. According to Hawari, the centre is responsible for monitoring the capacity of public hospitals and pharmaceutical warehouses to ensure optimal distribution of patients to hospitals to alleviate overcrowding and reduce waste of medical supplies and medicines, the statement said. The Crown Prince attended a meeting held at the centre for the National Council for Future Technology's digital committee on the health sector, during which His Royal Highness was briefed on the council's future plans and strategies to raise the level of health services. The Crown Prince also visited Salt Comprehensive Healthcare Centre, which was recently rehabilitated, to check on the services provided, including the introduction and standardisation of electronic payment services.
Yahoo
2 days ago
- Business
- Yahoo
Market to Surpass $250 Billion by 2030, Driven by Virtual Consultations, Government Investment, and Emerging AI- and IoT-Powered Care Platforms
The telemedicine technologies market report offers in-depth analysis, trends, and forecasts through 2030. It covers major players, innovations, and geographic opportunities. Key insights include market dynamics, patient subscription software, and virtual consultations. The report details regulatory assessments, emerging technologies, and market rankings. Regional segments and major country analyses are included, with estimates providing revenue data from 2022-2030 and insights into sustainability trends, ESG developments, and patent grants. Major companies profiled include Siemens Healthineers and Teladoc Health. Global Telemedicine Technologies Market Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Global Markets for Telemedicine Technologies" report has been added to global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030. This report provides an analysis of the telemedicine technologies market, including market estimations and trends through 2030. It examines major players, competitive insights, innovations, advertising flow, geographic opportunities and territorial openings. The report addresses major players' acquisitions, collaborations, partnerships and item portfolios. It covers drivers, restraints, opportunities, emerging technologies and a regulatory scenario assessment. The report also includes market projections through 2030 and market rankings for key players. Telemedicine transmits biomedical data between patients and caregivers at different locations without face-to-face contact. It saves time and money on healthcare services by providing remote medication, eliminating the need to travel to see a physician. Telemedicine provides expert-based medical care to any place where it is needed without physical contact. It uses existing wired and wireless infrastructures for both prototype and real-time key players in the global telemedicine technologies market are Siemens Healthineers, Koninklijke Philips N.V., Teladoc Health, American Well Corp. (Amwell), Doximity Inc. and SHL Telemedicine. These companies focus on developing telemedicine virtual consultation platforms using hardware, software and Dynamics and Growth FactorsThe global market for telemedicine technologies was valued at $133.7 billion in 2024. The growth rate is attributed to increased virtual consultations between patients and physicians, repetitive virtual consultations for serious illnesses, government investment in digital healthcare and the expansion of telemedicine companies in regions such as North America, Europe and Asia-Pacific. Numerous digital health technologies, such as electronic decision-support tools, telemonitoring, remote monitoring and mobile health applications, are available in developed and emerging countries and are estimated to propel market growth. The increased rate of minimally invasive surgery for patients in Asia-Pacific and European countries, improved virtual consultation technology, increased virtual meetings between patients and physicians, patient convenience and a large geriatric population are several factors driving the global market for telemedicine TechnologiesBeginning in 2024, the healthcare industry has experienced significant transformation driven by advances in telemedicine. Healthcare systems have been upgraded with skilled professionals trained to use new technologies, improving care delivery in emergency rooms and remote locations. The global expansion of clinics and hospitals has further increased the demand for digital tools in healthcare. Concurrently, home care technologies are growing rapidly, fueled by an aging population and rising rates of disability and chronic illness. Moving forward, the focus will shift to software-based devices powered by AI and the Internet of Things (IoT), enabling more personalized, patient-centric care through innovative telemedicine platforms and applications. Report Includes 48 data tables and 75 additional tables Analyses of the trends in the global markets for telemedicine technologies, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030 Estimates of the size and revenue prospects for the global market, along with a market share analysis by business offering (components), technology type, application, end user, and region Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations, and the impacts of macroeconomic variables Insights derived from the Porter's Five Forces model, as well as global supply chain analyses An assessment of the telemedicine products and technologies currently available, as well as new developments, spending trends, and growth prospects for this innovation-driven market Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes A review of patent activity and key patent grants Analysis of the industry structure, including companies' product offerings, strategic alliances, M&A activity, venture fundings and investment outlook Profiles of the leading companies, including Siemens Healthineers AG, Koninklijke Philips N.V., Teladoc Health, American Well Corp., and SHL Telemedicine Ltd. Key Attributes: Report Attribute Details No. of Pages 209 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $146.9 Billion Forecasted Market Value (USD) by 2030 $251.5 Billion Compound Annual Growth Rate 11.3% Regions Covered Global Key Topics Covered: Chapter 1 Introduction Market Outlook Scope of the Report Market Summary Market Dynamics and Growth Factors Emerging Technologies Segment Analysis Regional Analysis Conclusion Chapter 2 Market Overview Introduction to Telemedicine Key Communication Technologies and Components of Telemedicine Benefits of Telemedicine Telemedicine Uses and Patient Preferences Macroeconomic Factors Analysis Porter's Five Forces Analysis Bargaining Power of Suppliers Bargaining Power of Buyers Threat of New Entrants Threat of Substitutes Competitive Rivalry/Degree of Competition Chapter 3 Market Dynamics Market Dynamics Key Takeaways Market Drivers Asynchronous Telemedicine Trend Development of the Internet of Things in Telemedicine Telemedicine for Chronic Disease Management Advances in Digital Healthcare Evolving Insurance Sectors Market Restraints Communication Errors Implementation of Telemedicine into Legacy Systems Regulatory Obstacles Market Opportunities Favorable Government Initiatives Acceptance of Telemedicine in Emerging Countries Chapter 4 Regulatory Landscape Regulatory Scenario Legal Aspects of Telemedicine in Various Countries and Their Associated Challenges Chapter 5 Emerging Technologies and Developments Telemedicine Technologies: Overview Telesurgery Telepsychiatry Teleophthalmology Emerging Technologies for Telemedicine Technological Advances in Patient Care Cloud-Based Software Devices Digital Biomarkers Artificial Intelligence in Radiology Internet of Medical Things Patent Analysis Key Findings Chapter 6 Market Segmentation Analysis Segmentation Breakdown Market Analysis by Application Key Takeaways Remote Imaging Telepathology Teledermatology Remote Surgery Telepsychiatry Telecardiology Other Applications Market Analysis by Business Segment Key Takeaways Services Software Hardware Market Analysis by End User Key Takeaways Home Healthcare Healthcare Providers Other End Users Geographic Breakdown Market Analysis by Region Key Takeaways North America Europe Asia-Pacific South America Middle East and Africa Chapter 7 Competitive Intelligence Key Takeaways Competitive Landscape Global Market Shares of Leading Companies Key Developments and Strategies Partnerships and Collaborations Business Expansions Product Launches, Enhancements and Expansions Acquisitions Chapter 8 Sustainability in Telemedicine System: An ESG Perspective Introduction to ESG Implementation of ESG by Healthcare Providers and Payers Key Challenges to Implementing ESG Practices ESG Risk Ratings ESG Practices in the Telemedicine Technologies Industry Environmental Performance Social Performance Governance Performance Concluding Remarks Chapter 9 Appendix Research Methodology References Abbreviations Company Profiles American Well Amc Health Cisco Systems Inc. Cvs Health Doximity Inc. Ge Healthcare Globalmed Holdings Llc. Imedtac Co. Ltd. Koninklijke Philips N.V. Medtronic Siemens Healthnieers Ag Shl Telemedicine Teladoc Health Inc. Telespecialists Tigerconnect For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Global Telemedicine Technologies Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
23-07-2025
- Business
- Associated Press
Avel eCare Appoints Martainn Lenhardt as Chief Financial Officer to Lead Financial Strategy Amid Rapid Growth and Innovation
SIOUX FALLS, SD / ACCESS Newswire / July 23, 2025 / Avel eCare, a leading provider of telemedicine services in the United States, today announced the appointment of Martainn Lenhardt as Chief Financial Officer (CFO). Lenhardt brings over 20 years of healthcare finance experience to the role, where he will oversee Avel's financial strategy, operations, and performance during a pivotal era of innovation and nationwide expansion. Lenhardt joins Avel eCare following his tenure as VP of Finance at Lyric and senior leadership roles at Change Healthcare, where he managed a $480 million business unit and was instrumental in driving growth and improving margins. He is widely recognized for his expertise in strategic growth, mergers and acquisitions, and optimizing global operations. His ability to turn complexity into opportunity and build agile, purpose-driven teams will be instrumental in advancing Avel's mission. 'Avel eCare is transforming how healthcare is delivered across the country,' said Lenhardt. 'It's an honor to join this team and help scale a model that brings high-quality, virtual care to every corner of the nation.' This appointment comes at a time of unprecedented momentum for Avel eCare. In the past two years alone, Avel has launched new service lines, secured exclusive partnerships with organizations like Amwell and Cibolo Health, and expanded services to more than 46 states. The company continues to innovate with in-ambulance telehealth, ICU solutions, and programs that support EMS, law enforcement, and correctional health, making care more accessible, cost-effective, and consistent, especially in rural and underserved areas. The new CFO joins an accomplished executive team committed to advancing healthcare access and outcomes across the country. Avel's leadership includes: About Avel eCare Avel eCare is a national leader in technology-enabled clinical services delivered through telemedicine, offering provider-to-provider virtual care solutions that expand clinical capacity and improve outcomes across the healthcare industry. With more than 30 years of innovation, Avel's board-certified clinicians partner with hospitals, clinics, long-term care facilities, schools, EMS agencies, and correctional health systems nationwide to bring high-quality care to patients when and where it's needed most. Learn more at: Media Contact: Jessica Gaikowski Avel eCare [email protected] SOURCE: Avel eCare press release
Yahoo
18-07-2025
- Health
- Yahoo
Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR
DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2032, culminating in a forecasted valuation of US$11.6 billion by the end of the period. The sleep apnea devices market is experiencing significant growth, primarily driven by the increasing integration of telemedicine, mobile health (mHealth), and artificial intelligence in the diagnostic and therapeutic processes for sleep apnea. The expansion of key market players into emerging economies like India, Australia, the UAE, and Saudi Arabia is further enhancing this market's potential. Additionally, there is a notable trend among health agencies to expand reimbursement policies for remote patient monitoring and related connected healthcare services, which is improving accessibility to advanced sleep apnea management solutions. Furthermore, innovative developments such as compact positive airway pressure (PAP) devices and wearable sleep monitoring technologies are gaining traction, reshaping the dynamics of the sleep apnea devices market. Download PDF Brochure: Browse in-depth TOC on 'Sleep Apnea Devices Market' 739 - Tables51 - Figures497 - Pages By product type, the sleep apnea devices market is categorized into two main product types: therapeutic devices and diagnostic devices. In 2024, the therapeutic devices segment emerged as the dominant player in the market, capturing the largest share. This growth can be attributed to continuous advancements in technology focused on increasing patient comfort and enhancing the overall user experience, which in turn fosters better adherence to therapy. Leading the charge in this segment are prominent companies such as ResMed from the United States, Koninklijke Philips N.V. based in the Netherlands, and Fisher & Paykel Healthcare Limited from New Zealand, all of which are renowned for their innovative solutions in the field of sleep apnea management. By end users, the sleep apnea devices market is segmented by end user into several categories, including hospitals, home care settings, sleep clinics, ambulatory care centers, primary care centers, and other specialized end users. As we look ahead to 2024, it is anticipated that home care settings and individual users will dominate the market, capturing the largest share. This trend can be attributed to a growing preference for home-based diagnosis and treatment options, which effectively eliminates the need for patients to travel to sleep centers for their care. The convenience of being able to monitor and manage sleep apnea from the comfort of one's home has significantly enhanced the accessibility of these devices. This shift not only appeals to patients seeking a more comfortable treatment experience but also addresses the ongoing demand for efficient and timely care in the face of increasing patient volumes. Ultimately, these factors collaborate to drive substantial growth in the market for sleep apnea devices. By geography, the global market for sleep apnea devices has been segmented into six major geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America stood out as the largest market for sleep apnea devices in 2024. Several factors contribute to North America's market leadership. Firstly, there is a high level of public awareness regarding sleep apnea and its associated health risks, which encourages individuals to seek diagnosis and treatment. Additionally, the region boasts widespread access to advanced diagnostic technologies, enabling healthcare providers to accurately identify sleep apnea cases and recommend appropriate devices. Moreover, favorable reimbursement policies play a significant role in facilitating the adoption of these medical devices. Insurers are increasingly covering expenses related to sleep apnea treatments, making it more financially viable for patients to invest in devices that improve their quality of sleep and overall health. As a result, the combination of heightened awareness, access to cutting-edge technology, and supportive healthcare policies has led to a notable increase in the adoption of sleep apnea devices throughout North America. Request Sample Pages: The major players operating in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical SE & Co. KG (Germany), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. KG (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US) ResMed (US): In 2024, ResMed, a leading company based in the United States, captured the largest market share in the global sleep apnea devices sector. The company has built a strong reputation for its innovative and highly effective therapeutic and diagnostic solutions, particularly in sleep health. ResMed's success is primarily attributed to its extensive expertise in healthcare technology, which allows it to develop sleep apnea devices that deliver both accuracy and efficacy in treatment. Over the past few years, ResMed has significantly broadened its product portfolio, focusing on positive airway pressure (PAP) devices and facial interfaces that enhance user comfort and compliance. This expansion diversifies its offerings and positions ResMed to meet broader patient needs and preferences. By continually advancing its technology and product design, the company has maintained its status as the market leader in sleep apnea solutions. It is committed to improving patient outcomes and quality of life. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V., headquartered in the Netherlands, was the second-largest company in market share in 2024. Renowned for its expertise in the sleep apnea sector, Philips has established itself as a vital contributor to health monitoring and respiratory care. The company has gained recognition for its innovative and user-centric devices designed to enhance the quality of life for individuals suffering from sleep apnea. In recent years, Philips has sought to expand its global presence through strategic partnerships and acquisitions. These initiatives aim to improve accessibility to sleep apnea solutions and increase awareness about the condition, particularly in emerging and developing markets where health challenges are often underrecognized. By aligning with local healthcare providers and leveraging regional insights, Philips is working to ensure that effective treatment options reach a wider audience, contributing to better overall health outcomes for sleep apnea patients. Fisher & Paykel Healthcare Limited (New Zealand) Fisher & Paykel Healthcare Limited, based in New Zealand, is anticipated to capture the third-largest market share of sleep apnea devices by 2024. The company strategically distributes its innovative sleep apnea products across two primary segments: the Hospital and Homecare sectors. Fisher & Paykel is committed to elevating patient care by continuously enhancing its product offerings, emphasizing advanced humidification systems and state-of-the-art mask technologies. These improvements are designed to improve patient comfort during therapy and optimize therapeutic outcomes, ensuring that users experience effective and comfortable treatment for their sleep apnea. Through these efforts, the company aims to solidify its position as a leader in the sleep apnea market while improving the quality of life for patients globally. For more information, Inquire Now! Related Reports: Pulse Oximeter Market Patient Monitoring Devices Market Home Healthcare Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Sleep Apnea Devices Companies and Sleep Apnea Devices Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
